These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36711379)

  • 1. Two-year follow-up of the COVID-19 pandemic in Mexico.
    Loza A; Wong-Chew RM; Jiménez-Corona ME; Zárate S; López S; Ciria R; Palomares D; García-López R; Iša P; Taboada B; Rosales M; Boukadida C; Herrera-Estrella A; Mojica NS; Rivera-Gutierrez X; Muñoz-Medina JE; Salas-Lais AG; Sanchez-Flores A; Vazquez-Perez JA; Arias CF; Gutiérrez-Ríos RM
    Front Public Health; 2022; 10():1050673. PubMed ID: 36711379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative epidemiology of five waves of COVID-19 in Mexico, March 2020-August 2022.
    Ascencio-Montiel IJ; Ovalle-Luna OD; Rascón-Pacheco RA; Borja-Aburto VH; Chowell G
    BMC Infect Dis; 2022 Oct; 22(1):813. PubMed ID: 36316634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico.
    Parra-Bracamonte GM; Lopez-Villalobos N; Parra-Bracamonte FE
    Ann Epidemiol; 2020 Dec; 52():93-98.e2. PubMed ID: 32798701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico.
    Domínguez-Ramírez L; Solis-Tejeda I; Ayon-Aguilar J; Mayoral-Ortiz A; Sosa-Jurado F; Pelayo R; Santos-López G; Cortes-Hernandez P
    Front Public Health; 2022; 10():1010256. PubMed ID: 36176536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico.
    Chowell G; Viboud C; Simonsen L; Miller MA; Echevarría-Zuno S; González-León M; Aburto VH
    BMC Infect Dis; 2012 Apr; 12():97. PubMed ID: 22520743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fatalities due to COVID-19 and other nonexternal causes during the first five pandemic waves : Results from multiple cause of death statistics in Bavaria.
    Buschner A; Katz K; Beyerlein A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2024 Aug; 67(8):939-946. PubMed ID: 39012367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first wave of the COVID-19 pandemic in Spain: characterisation of cases and risk factors for severe outcomes, as at 27 April 2020.
    ;
    Euro Surveill; 2020 Dec; 25(50):. PubMed ID: 33334400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
    Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.
    Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR
    Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients with COVID-19 in Mexico.
    Peña JE; Rascón-Pacheco RA; Ascencio-Montiel IJ; González-Figueroa E; Fernández-Gárate JE; Medina-Gómez OS; Borja-Bustamante P; Santillán-Oropeza JA; Borja-Aburto VH
    Arch Med Res; 2021 May; 52(4):443-449. PubMed ID: 33380361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year.
    Ward JL; Harwood R; Smith C; Kenny S; Clark M; Davis PJ; Draper ES; Hargreaves D; Ladhani S; Linney M; Luyt K; Turner S; Whittaker E; Fraser LK; Viner RM
    Nat Med; 2022 Jan; 28(1):193-200. PubMed ID: 34931076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.
    Torres-Ibarra L; Basto-Abreu A; Carnalla M; Torres-Alvarez R; Reyes-Sanchez F; Hernández-Ávila JE; Palacio-Mejia LS; Alpuche-Aranda C; Shamah-Levy T; Rivera JA; Barrientos-Gutierrez T
    Int J Epidemiol; 2022 May; 51(2):429-439. PubMed ID: 35157072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves.
    Sadeghi F; Halaji M; Shirafkan H; Pournajaf A; Ghorbani H; Babazadeh S; Ezami N; Fallhpour K; Fakhraie F; Gorjinejad S; Amoli SS; Amiri FH; Baghershiroodi M; Ahmadnia Z; Salehi M; Tourani M; Jafarzadeh J; Tabari FS; Ahmadian SR; Mohammadi Abandansari R; Jafarian F; Rouhi S; Zabihollahi A; Mostafanezhad S; Saeedi F; Ebrahimian A; Deldar Z; Zavareh MSH; Bayani M; Broun MB; Shirzad M; Sabbaghi S; Mohammadi M; Rahmani R; Yahyapour Y
    BMC Infect Dis; 2024 Jan; 24(1):55. PubMed ID: 38184533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 in-hospital mortality during the first two pandemic waves, at Helen Joseph Hospital, South Africa.
    Reid J; Daya R; Zingoni ZM; Jassat W; Bayat Z; Nel J
    Pan Afr Med J; 2023; 45():5. PubMed ID: 37346915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial modeling, risk mapping, change detection, and outbreak trend analysis of coronavirus (COVID-19) in Iran (days between February 19 and June 14, 2020).
    Pourghasemi HR; Pouyan S; Heidari B; Farajzadeh Z; Fallah Shamsi SR; Babaei S; Khosravi R; Etemadi M; Ghanbarian G; Farhadi A; Safaeian R; Heidari Z; Tarazkar MH; Tiefenbacher JP; Azmi A; Sadeghian F
    Int J Infect Dis; 2020 Sep; 98():90-108. PubMed ID: 32574693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity.
    Borja-Aburto VH; Chowell G; Viboud C; Simonsen L; Miller MA; Grajales-Muñiz C; González-Bonilla CR; Diaz-Quiñonez JA; Echevarría-Zuno S
    Arch Med Res; 2012 Oct; 43(7):563-70. PubMed ID: 23079035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of 4963 deaths associated with COVID-19 during three pandemic waves in a Latin American city with a high mortality rate, 2020-2021.
    Viana-Cárdenas E; Triana A; Mendoza H; Buendia E; Viasus D
    Trop Med Int Health; 2022 Feb; 27(2):158-164. PubMed ID: 34873803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidities that predict acute respiratory syndrome coronavirus 2 test positivity in Mexican Children: A case-control study.
    Hernández-Garduño E
    Pediatr Obes; 2021 May; 16(5):e12740. PubMed ID: 33040467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.